Pelage Pharmaceuticals Appoints New Board Member and Expands Executive Leadership Team

요약

“Pelage Pharmaceuticals appoints Maykin Ho, Ph.D., to its board of directors”
“Nathan Wheeler promoted to Chief Operating Officer and Lisa Sherman to VP of Clinical Operations”
“Leadership changes support upcoming late-stage trials of PP405 in androgenetic alopecia”

Profit ▲ Debt high Cash good Growth slow Valuation neutral Drawdown low

Pelage Pharmaceuticals, 신규 이사 및 임원 확대 발표
Pelage Pharmaceuticals, Maykin Ho 박사를 이사회에 임명
Nathan Wheeler COO, Lisa Sherman VP of Clinical Operations로 승진
PP405 후기 임상시험 지원을 위한 리더십 변화

출처: PharmiWeb.com
링크: https://www.pharmiweb.com/press-release/2026-02-23/pelage-pharmaceuticals-appoints-new-board-member-and-expands-executive-leadership-team

소셜 공유 미리보기(OG) 전용 페이지입니다.